UK markets close in 4 hours 6 minutes

B.R.A.I.N. Biotechnology Research and Information Network AG (BNN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.7100-0.1600 (-5.57%)
As of 09:03AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 60.74M
Enterprise value 59.99M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.15
Price/book (mrq)3.26
Enterprise value/revenue 1.10
Enterprise value/EBITDA -31.67

Trading information

Stock price history

Beta (5Y monthly) 1.28
52-week change 3-53.62%
S&P500 52-week change 324.19%
52-week high 35.8000
52-week low 32.6500
50-day moving average 33.5068
200-day moving average 33.8876

Share statistics

Avg vol (3-month) 3319
Avg vol (10-day) 3237
Shares outstanding 521.85M
Implied shares outstanding 623.39M
Float 89.09M
% held by insiders 160.62%
% held by institutions 113.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -15.20%
Operating margin (ttm)-16.91%

Management effectiveness

Return on assets (ttm)-5.06%
Return on equity (ttm)-31.78%

Income statement

Revenue (ttm)55.23M
Revenue per share (ttm)2.53
Quarterly revenue growth (yoy)-7.20%
Gross profit (ttm)N/A
EBITDA -2.51M
Net income avi to common (ttm)-8.39M
Diluted EPS (ttm)-0.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.55M
Total cash per share (mrq)0.21
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.64
Book value per share (mrq)0.94

Cash flow statement

Operating cash flow (ttm)-4.82M
Levered free cash flow (ttm)-6.65M